Tilray Brands Inc (TLRY)
0.431
-0.03
(-7.23%)
USD |
NASDAQ |
May 30, 16:00
0.4249
-0.01
(-1.42%)
After-Hours: 20:00
Key Stats
Price and Performance | |
---|---|
Market Cap | 437.86M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -74.33% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 0.4488 |
Price to Book Value | 0.1604 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.1015 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 99.31% |
Profile
Edit
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol. |
URL | https://www.tilray.com |
Investor Relations URL | https://ir.tilray.com/ |
HQ State/Province | Ontario |
Sector | Health Care |
Industry | Pharmaceuticals |
Next Earnings Release | Jul. 29, 2025 (est.) |
Last Earnings Release | Apr. 08, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Edit
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol. |
URL | https://www.tilray.com |
Investor Relations URL | https://ir.tilray.com/ |
HQ State/Province | Ontario |
Sector | Health Care |
Industry | Pharmaceuticals |
Next Earnings Release | Jul. 29, 2025 (est.) |
Last Earnings Release | Apr. 08, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |